Guj. Inject(Ker)

Why is Gujarat Inject (Kerala) Ltd falling/rising?

As of 10-Aug, Gujarat Inject (Kerala) Ltd's stock price has risen to 10.92, reflecting a 4.2% increase. Despite a recent decline in investor participation, the stock has shown strong long-term performance with a 205.03% year-to-date increase and a 420.00% rise over the past year.

As of 10-Aug, Gujarat Inject (Kerala) Ltd is experiencing a rise in its stock price, currently at 10.92, which reflects an increase of 0.44 or 4.2%. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 14.35% while the Sensex has seen a slight decline of 0.12%. Additionally, the stock has shown a strong performance over the last four days, with a cumulative return of 21.15%.<BR><BR>Despite a decline of 20.00% over the past month, the year-to-date performance remains robust at +205.03%, and the stock has achieved an impressive 420.00% increase over the past year. The long-term performance is even more striking, with a 1265.00% rise over the last three years. <BR><BR>However, it is important to note that there has been a decrease in investor participation, as indicated by a 6.97% drop in delivery volume compared to the five-day average. This could suggest a potential concern regarding sustained interest in the stock. Nevertheless, the current price is above the 5-day, 100-day, and 200-day moving averages, indicating a positive short-term trend despite being lower than the 20-day and 50-day moving averages. Overall, the combination of recent gains and strong long-term performance contributes to the stock's rising price.

Which are the latest news on Guj. Inject(Ker)?

What does Guj. Inject(Ker) do?

Gujarat Inject (Kerala) Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 1991, with recent quarterly net sales of 31 Cr and a net profit of 2 Cr as of March 2026. The company has no debt and a market cap of INR 174 Cr.

Overview:<BR>Gujarat Inject (Kerala) Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in January 1991 and initially promoted by Gujarat Inject Limited and the Kerala State Industrial Development Corporation. There were no operations during the first half of the year 1998-99. The company entered into a manufacturing contract with a reputed I.V. Fluid manufacturer in the second half of the year 1999. The latest reported quarter for net sales and profit is March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 31 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 2 Cr (Quarterly Results - Mar 2026)<BR>- Market cap: INR 174 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- Industry P/E: 34<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.00<BR>- Return on Equity: 0.00%<BR>- Price to Book: 0.00<BR><BR>Contact Details:<BR>Address: Bldg No XVII/1103 Kanjikode, Sarayu Arcade Satrapadi Palakkad Kerala : 678621<BR>Website: http://www.gujaratinject.com

How big is Guj. Inject(Ker)?

As of 10th June, Gujarat Inject (Kerala) Ltd has a market capitalization of 174.00 Cr, with recent net sales of 36.33 Cr and a net profit of 1.82 Cr. Shareholder's funds are 10.01 Cr and total assets amount to 11.95 Cr.

As of 10th June, Gujarat Inject (Kerala) Ltd has a market capitalization of 174.00 Cr, classified as a Micro Cap.<BR><BR>In the latest four quarters, the company reported Net Sales of 36.33 Cr and a Net Profit of 1.82 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 10.01 Cr and Total Assets of 11.95 Cr.

Who are in the management team of Guj. Inject(Ker)?

The management team of Guj. Inject(Ker) consists of Murli Shivshankaran Nair (Whole Time Director & CFO), Reena Mahatma (Director), and independent directors Narayansinh Padudansinh Chauhan and Gautam Keshavlal Chauhan.

The management team of Guj. Inject(Ker) includes the following individuals:<BR><BR>1. **Murli Shivshankaran Nair** - Whole Time Director & CFO<BR>2. **Reena Mahatma** - Director<BR>3. **Narayansinh Padudansinh Chauhan** - Independent Director<BR>4. **Gautam Keshavlal Chauhan** - Independent Director<BR><BR>If you need more information about their roles or the company, feel free to ask!

Who are the peers of the Guj. Inject(Ker)?

Peers of Guj. Inject(Ker) include Oxygenta Pharma, Coral Labs, Sanjiv. Parant, Auro Labs, Natural Capsules, Panch. Organics, and Quest Laborato. Guj. Inject(Ker) leads in 1-year returns at 427.17%, while Oxygenta Pharma has the lowest at -60.96%.

Peers: The peers of Guj. Inject(Ker) are Oxygenta Pharma, Coral Labs., Sanjiv.Parant., Auro Labs., Natural Capsules, Panch.Organics, and Quest Laborato.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sanjiv.Parant. and Quest Laborato., while Good management risk is found at Coral Labs. Average management risk is present at Auro Labs. and Panch.Organics, and Below Average management risk is noted at Oxygenta Pharma and Natural Capsules. In terms of Growth, Good growth is seen at Sanjiv.Parant. and Quest Laborato., while Average growth is found at Auro Labs. and Panch.Organics, and Below Average growth is noted at Coral Labs., Oxygenta Pharma, and Natural Capsules. For Capital Structure, Excellent capital structure is observed at Coral Labs. and Quest Laborato., while Average capital structure is found at Panch.Organics, and Below Average capital structure is noted at Oxygenta Pharma, Auro Labs., Natural Capsules, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Guj. Inject(Ker) at 427.17%, while the peer with the lowest 1-year return is Oxygenta Pharma at -60.96%. Guj. Inject(Ker)'s return significantly outperforms all peers. Additionally, Oxygenta Pharma, Auro Labs., Natural Capsules, and Panch.Organics have negative six-month returns.

When is the next results date for Gujarat Inject (Kerala) Ltd?

The next results date for Gujarat Inject (Kerala) Ltd is 14 February 2026.

The next results date for Gujarat Inject (Kerala) Ltd is scheduled for 14 February 2026.

How has been the historical performance of Guj. Inject(Ker)?

Guj. Inject(Ker) has shown significant growth from March 2022 to March 2025, with net sales increasing from 0.02 crore to 19.05 crore and operating profit turning positive at 1.26 crore. The company also improved its profit before tax to 1.25 crore and earnings per share rose to 0.7, indicating strong revenue and profitability growth.

Answer:<BR>The historical performance of Guj. Inject(Ker) shows significant growth in net sales and profitability over the years, particularly from March 2022 to March 2025.<BR><BR>Breakdown:<BR>Guj. Inject(Ker) experienced a remarkable increase in net sales, rising from just 0.02 crore in March 2022 to 19.05 crore in March 2025. This growth is reflected in total operating income, which also surged from 0.02 crore in March 2022 to 19.05 crore in March 2025. The company's total expenditure, excluding depreciation, increased from 0.07 crore in March 2022 to 17.97 crore in March 2025, indicating a rise in operational costs alongside revenue growth. Operating profit, which was negative in earlier years, turned positive, reaching 1.26 crore in March 2025, with an operating profit margin of 5.67%. Profit before tax also improved significantly, from 0.00 crore in March 2022 to 1.25 crore in March 2025, leading to a profit after tax of 1.02 crore in the same period. The earnings per share (EPS) rose from 0.0 in March 2022 to 0.7 in March 2025, showcasing enhanced shareholder value. Overall, the financial data indicates a strong upward trend in both revenue and profitability for Guj. Inject(Ker) over the analyzed period.

Who are the top shareholders of the Guj. Inject(Ker)?

The top shareholders of Guj. Inject(Ker) are mainly individual investors, holding 83.95% of shares, with Jignesh Shivlal Makasana as the largest public shareholder at 11.95%. There are no institutional holdings or pledged promoter shares.

The top shareholders of Guj. Inject(Ker) are primarily individual investors, who hold a significant 83.95% of the shares. Among public shareholders, Jignesh Shivlal Makasana stands out with a holding of 11.95%. There are no institutional holdings from mutual funds or foreign institutional investors, and there are no pledged promoter holdings. The majority of the shares are held by non-institutional entities.

What is the technical trend for Guj. Inject(Ker)?

As of May 22, 2025, the technical outlook is mildly bullish, supported by daily moving averages and KST indicators, despite mixed signals from the Bollinger Bands and a bearish weekly MACD.

As of 22 May 2025, the technical trend has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly MACD shows a mildly bearish trend. The Bollinger Bands present a mixed view with a bearish signal on the weekly and a mildly bullish signal on the monthly. The KST is bullish on the weekly timeframe, supporting the mildly bullish outlook. However, the weekly Dow Theory indicates a bullish trend, while the monthly shows no trend. Overall, the current technical stance is mildly bullish, driven primarily by daily moving averages and KST indicators.

Has Guj. Inject(Ker) declared dividend?

No Dividend History Available